Covid-19 research: Inhaled multiple sclerosis drug 'speeds recovery'

Just 13 per cent of Covid-19 hospital patients given SNG001 fell ill enough to need intensive care, compared to 22 per cent of those on a placebo, the Southampton University study found.

from Health News | Mail Online https://ift.tt/3ko2N35